Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lutronic, which develops and manufactures aesthetic and medical laser systems, has received regulatory clearance from the FDA for the eCO2 system.
Subscribe to our email newsletter
Using the proprietary controlled chaos technology (CCT), this next generation fractional CO2 laser is said to be designed to offer a safe and innovative way to treat deep ablative indications such as resurfacing and coagulation of soft tissue, textural irregularities, fine lines, pigmented lesions, vascular dyschromia, and rhytides.
According to the company, the eCO2 has added multifunctional features, including an intuitive software that can select between a random or sequential beam pattern, as well as a built-in skin sensor technology that prevents the laser from firing unless the handpiece tip is in contact with the skin.
A wide range of indications may be treated with its three different treatment tip sizes, including a point beam tip for traditional CO2 excision and vaporization of tissue-tags and pigmented lesions.
David Holcomb, immediate past president of the Florida society of facial plastic surgeons, said: “The eCO2 is a familiar wavelength in an extremely elegant and versatile package, with the ability to perform incisional surgery, traditional ablative resurfacing and ablative microfractional photothermolysis.”